H.R. 5939 · 116th Congress
Triple-Negative Breast Cancer Research and Education Act of 2019
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
Jackson LeeSponsorNo cosponsors.
Triple-Negative Breast Cancer Research and Education Act of 2019
What it does: CRS summary · Introduced in House · Feb 21, 2020
Triple-Negative Breast Cancer Research and Education Act of 2019
This bill requires research and education activities related to triple-negative breast cancer. (The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein.)
The National Institutes of Health must conduct and support research into the disease, and the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop and disseminate information about triple-negative breast cancer for the public and for health care providers, respectively. Among other topics, the information must cover the elevated risk for minority women and the availability of a range of treatment options for such cancers.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Triple-Negative Breast Cancer Research and Education Act of 2019
Latest action (Feb 21, 2020): Referred to the House Committee on Energy and Commerce.
Policy area: Health · Origin: House · Introduced: Feb 21, 2020
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.